Cognizant
CTSH Nasdaq IT Consulting & Other Services Financials FY2016–FY2025
Cognizant's revenue rose 7.0% to $21.1 billion in fiscal 2025. Its operating margin was 16.1%, up from 14.7% a year earlier. Free cash flow was $2.6 billion, up 42.0%. It paid out $2.0 billion in dividends and buybacks, 77% of free cash flow. The diluted share count fell 1.6%.
What Cognizant does
Cognizant is an information technology services company. It builds and maintains software for large businesses, moves their systems to the cloud, tests software, runs computer infrastructure and security, handles back-office work such as claims processing, and helps clients use AI. Its staff work both at client sites and in its own delivery centers around the world.
It reports four segments by the industry of its clients: Health Sciences, which serves hospitals, health insurers and drug and device makers; Financial Services, for banks, payment firms and insurers; Products and Resources, for manufacturers, carmakers, retailers, travel, energy and logistics companies; and Communications, Media and Technology. Revenues grew by $1,372 million, or 7.0%, in 2025, helped by its purchase of Belcan. Fixed-price contracts made up $10.0 billion of revenue, and the rest came from contracts billed by time and materials, by transaction or by volume. Its direct rivals include Accenture, Capgemini, Deloitte Digital, IBM Consulting, Infosys, Tata Consultancy Services and Wipro, plus clients' own technology staff.
At the end of 2025 Cognizant had about 351,600 employees, about 256,900 of them in India and 41,600 in North America.
- Legal name
- COGNIZANT TECHNOLOGY SOLUTIONS CORPORATION
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Feb 12, 2026
- Accession · CIK
- 0001058290-26-000008
0001058290
Revenue and margins
Cognizant had $21.1B of revenue in fiscal 2025, up 7.0% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew 6.7% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $2.6B in fiscal 2025, 12.3% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Cognizant returned $2.0B to shareholders in fiscal 2025, 77% of free cash flow. The diluted share count fell 1.6%.
Value Cognizant yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets — the answer depends entirely on what you put in.
Discounted cash flow
Value per share
—
Adds net cash of $1.3B and divides by 489.0M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
—
Reference multiples: today 15.3x · peers 21.4x · sector 33.5x.
Balance sheet
Cash, debt and the ratios that show how comfortably Cognizant can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $2.7B | $2.5B | $2.6B | $2.2B | $1.9B |
| Debt incl. finance leases | $677M | $659M | $663M | $931M | $598M |
| Net debt / EBITDA | −0.6x | −0.5x | −0.6x | −0.4x | −0.3x |
| Debt / equity | 0.1x | 0.1x | 0.1x | 0.1x | 0.0x |
| Interest coverage | 314.0x | 156.2x | 65.6x | 53.6x | 91.6x |
| Current ratio | 2.1x | 2.2x | 2.3x | 2.1x | 2.1x |
| Quick ratio | 2.1x | 2.2x | 2.3x | 2.1x | 2.1x |
| Total assets | $17.9B | $17.9B | $18.5B | $20.0B | $20.7B |
| Total liabilities | $5.9B | $5.5B | $5.3B | $5.6B | $5.7B |
| Shareholders' equity | $12.0B | $12.3B | $13.2B | $14.4B | $15.0B |
| Net debt (− = net cash) | −$2.0B | −$1.8B | −$2.0B | −$1.3B | −$1.3B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.2M
1 insider
Sold, 12 months
$1.0M
3 insiders
Of sales under plans
100%
$1.0M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Sep 30, 2026 | Alina KerdmanSVP, Controller & CAO | Sold plan | 139 | $56.88 | $0.0M | Form 4 |
| Sep 14, 2026 | Alina KerdmanSVP, Controller & CAO | Sold plan | 134 | $62.40 | $0.0M | Form 4 |
| Sep 2, 2026 | John Sunshin KimCLO, CAO & Corporate Secretary | Sold plan | 2,500 | $63.37 | $0.2M | Form 4 |
| Aug 31, 2026 | Alina KerdmanSVP, Controller & CAO | Sold plan | 144 | $63.34 | $0.0M | Form 4 |
| Aug 3, 2026 | Jatin P DalalChief Financial Officer | Sold plan | 12,000 | $55.76 | $0.7M | Form 4 |
| Aug 3, 2026 | John Sunshin KimCLO, CAO & Corporate Secretary | Sold plan | 2,500 | $57.05 | $0.1M | Form 4 |
| Jul 1, 2026 | Alina KerdmanSVP, Controller & CAO | Sold plan | 137 | $39.82 | $0.0M | Form 4 |
| Jun 15, 2026 | Alina KerdmanSVP, Controller & CAO | Sold plan | 133 | $51.70 | $0.0M | Form 4 |
| Jun 10, 2026 | Stephen J RohlederDirector | Bought | 4,034 | $52.00 | $0.2M | Form 4 |
| Jun 1, 2026 | Alina KerdmanSVP, Controller & CAO | Sold plan | 146 | $56.41 | $0.0M | Form 4 |
| May 18, 2026 | Alina KerdmanSVP, Controller & CAO | Sold plan | 154 | $48.04 | $0.0M | Form 4 |
| Apr 2, 2026 | Alina KerdmanSVP, Controller & CAO | Sold plan | 194 | $61.29 | $0.0M | Form 4 |
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | ✓ | ✓ | ✓ |
| Cash from operations is positive | ✓ | ✓ | ✓ |
| Return on assets rose | ✕ | ✓ | ✕ |
| Cash from operations exceeds net income | ✓ | ✕ | ✓ |
| Debt fell relative to assets | ✓ | ✕ | ✓ |
| Current ratio rose | ✓ | ✕ | ✓ |
| Share count didn't rise | ✓ | ✓ | ✓ |
| Gross margin rose | — | — | — |
| Revenue rose relative to assets | ✕ | ✕ | ✕ |
| F-score | 6 / 8 | 4 / 8 | 6 / 8 |
| Accruals ratio | −1.1% | 0.6% | −3.2% |
| Altman Z'' | 7.45 | 7.38 | 7.58 |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| Cognizant CTSH | $33.6B | 7.0% | 16.1% | 12.3% | 16.2% | 15.3x | 6 | |
| Kyndryl KD | $3.3B | 0.2% | — | 2.3% | 7.8% | 39.9x | 6 | Compare → |
| DXC Technology DXC | $2.7B | −1.8% | 7.7% | 8.2% | 9.2% | 21.2x | 7 | Compare → |
| IBM IBM | $241.8B | 7.6% | — | 17.9% | 15.4% | 21.6x | 6 | Compare → |
| Gartner IT | $15.3B | 3.7% | 15.8% | 18.1% | 44.6% | 20.8x | 5 | Compare → |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $13.5B | $14.8B | $16.1B | $16.8B | $16.7B | $18.5B | $19.4B | $19.4B | $19.7B | $21.1B |
| Operating income | $2.3B | $2.5B | $2.8B | $2.5B | $2.1B | $2.8B | $3.0B | $2.7B | $2.9B | $3.4B |
| Interest expense | $19.0M | $23.0M | $27.0M | $26.0M | $24.0M | $9.0M | $19.0M | $41.0M | $54.0M | $37.0M |
| Pretax income | $2.4B | $2.7B | $2.8B | $2.5B | $2.1B | $2.8B | $3.0B | $2.8B | $2.9B | $3.5B |
| Income tax | $805M | $1.2B | $698M | $643M | $704M | $693M | $730M | $668M | $713M | $1.3B |
| Net income | $1.6B | $1.5B | $2.1B | $1.8B | $1.4B | $2.1B | $2.3B | $2.1B | $2.2B | $2.2B |
| Diluted EPS | $2.55 | $2.53 | $3.60 | $3.29 | $2.57 | $4.05 | $4.41 | $4.21 | $4.51 | $4.56 |
| Diluted shares | 0.61B | 0.60B | 0.58B | 0.56B | 0.54B | 0.53B | 0.52B | 0.51B | 0.50B | 0.49B |
| Cash flow | ||||||||||
| Cash from operations | $1.6B | $2.4B | $2.6B | $2.5B | $3.3B | $2.5B | $2.6B | $2.3B | $2.1B | $2.9B |
| Capital expenditure | $300M | $284M | $377M | $392M | $398M | $279M | $332M | $317M | $297M | $288M |
| Free cash flow | $1.3B | $2.1B | $2.2B | $2.1B | $2.9B | $2.2B | $2.2B | $2.0B | $1.8B | $2.6B |
| Depreciation and amortization | $379M | $443M | $498M | $526M | $559M | $574M | $569M | $555M | $542M | $550M |
| Stock-based compensation | $217M | $221M | $267M | $217M | $232M | $246M | $261M | $176M | $175M | $181M |
| Acquisitions | $334M | $216M | $1.1B | $617M | $1.1B | $970M | $367M | $409M | $1.6B | $0.0M |
| Share buybacks | $512M | $1.9B | $1.3B | $2.2B | $1.6B | $771M | $1.4B | $1.1B | $605M | $1.4B |
| Dividends paid | $0.0M | $265M | $468M | $453M | $480M | $509M | $564M | $591M | $600M | $610M |
| Dividends and buybacks | $512M | $2.2B | $1.7B | $2.7B | $2.1B | $1.3B | $2.0B | $1.7B | $1.2B | $2.0B |
| Balance sheet | ||||||||||
| Cash and short-term investments | $5.2B | $5.1B | $4.5B | $3.4B | $2.7B | $2.7B | $2.5B | $2.6B | $2.2B | $1.9B |
| Total debt | $881M | $800M | $750M | $738M | $701M | $664M | $646M | $639M | $908M | $576M |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $26.0M | $22.0M | $13.0M | $13.0M | $24.0M | $23.0M | $22.0M |
| Current assets | $8.6B | $9.1B | $8.6B | $7.6B | $6.9B | $7.3B | $7.3B | $7.5B | $7.5B | $7.8B |
| Current liabilities | $2.4B | $2.8B | $2.7B | $3.0B | $3.5B | $3.5B | $3.3B | $3.3B | $3.6B | $3.7B |
| Inventory | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Property and equipment, net | $1.3B | $1.3B | $1.4B | $1.3B | $1.3B | $1.2B | $1.1B | $1.0B | $994M | $933M |
| Total assets | $14.3B | $15.2B | $15.8B | $16.2B | $16.9B | $17.9B | $17.9B | $18.5B | $20.0B | $20.7B |
| Total liabilities | $3.5B | $4.6B | $4.4B | $5.2B | $6.1B | $5.9B | $5.5B | $5.3B | $5.6B | $5.7B |
| Shareholders' equity | $10.7B | $10.7B | $11.4B | $11.0B | $10.8B | $12.0B | $12.3B | $13.2B | $14.4B | $15.0B |
| Margins | ||||||||||
| Operating margin | 17.0% | 16.8% | 17.4% | 14.6% | 12.7% | 15.3% | 15.3% | 13.9% | 14.7% | 16.1% |
| EBITDA margin | 19.8% | 19.7% | 20.5% | 17.8% | 16.1% | 18.4% | 18.2% | 16.8% | 17.4% | 18.7% |
| Net margin | 11.5% | 10.2% | 13.0% | 11.0% | 8.4% | 11.6% | 11.8% | 11.0% | 11.4% | 10.6% |
| FCF margin | 10.0% | 14.3% | 13.7% | 12.6% | 17.4% | 12.0% | 11.5% | 10.4% | 9.3% | 12.3% |
| Returns | ||||||||||
| Return on capital | 25.8% | 21.8% | 29.9% | 22.9% | 16.3% | 22.7% | 22.0% | 18.8% | 18.0% | 16.2% |
| Return on capital employed | 20.6% | 20.5% | 22.0% | 18.6% | 15.9% | 20.4% | 20.6% | 18.1% | 18.3% | 20.3% |
| Return on equity | 15.5% | 14.1% | 19.0% | 16.4% | 12.7% | 18.7% | 18.9% | 16.7% | 16.2% | 15.2% |
| Return on assets | 11.4% | 10.2% | 13.5% | 11.5% | 8.4% | 12.3% | 12.8% | 11.7% | 11.7% | 11.0% |
| Growth | ||||||||||
| Revenue growth | 8.6% | 9.8% | 8.9% | 4.1% | −0.8% | 11.1% | 5.0% | −0.4% | 2.0% | 7.0% |
| Net income growth | −4.4% | −3.2% | 39.7% | −12.3% | −24.4% | 53.5% | 7.2% | −7.2% | 5.4% | −0.5% |
| EPS growth | −3.8% | −0.8% | 42.3% | −8.6% | −21.9% | 57.6% | 8.9% | −4.5% | 7.1% | 1.1% |
| FCF growth | −29.7% | 57.8% | 4.3% | −4.9% | 37.7% | −23.6% | 0.9% | −10.0% | −9.2% | 42.0% |
| Share count change | −0.5% | −2.5% | −1.9% | −4.1% | −3.4% | −2.4% | −1.7% | −2.7% | −1.6% | −1.6% |
| Financial health | ||||||||||
| Net debt / EBITDA | −1.6x | −1.5x | −1.1x | −0.9x | −0.8x | −0.6x | −0.5x | −0.6x | −0.4x | −0.3x |
| Debt / equity | 0.1x | 0.1x | 0.1x | 0.1x | 0.1x | 0.1x | 0.1x | 0.1x | 0.1x | 0.0x |
| Interest coverage | 120.5x | 107.9x | 103.7x | 94.4x | 88.1x | 314.0x | 156.2x | 65.6x | 53.6x | 91.6x |
| Current ratio | 3.6x | 3.2x | 3.2x | 2.6x | 1.9x | 2.1x | 2.2x | 2.3x | 2.1x | 2.1x |
| Quick ratio | 3.6x | 3.2x | 3.2x | 2.6x | 1.9x | 2.1x | 2.2x | 2.3x | 2.1x | 2.1x |
| Capital allocation | ||||||||||
| Capex / revenue | 2.2% | 1.9% | 2.3% | 2.3% | 2.4% | 1.5% | 1.7% | 1.6% | 1.5% | 1.4% |
| Stock comp / revenue | 1.6% | 1.5% | 1.7% | 1.3% | 1.4% | 1.3% | 1.3% | 0.9% | 0.9% | 0.9% |
| Payouts / FCF | 38.1% | 101.5% | 78.1% | 128.1% | 72.4% | 57.8% | 88.8% | 82.2% | 66.0% | 76.6% |
| Quality scores | ||||||||||
| Piotroski F-score | 6.0 | 6.0 | 7.0 | 5.0 | 5.0 | 8.0 | 7.0 | 6.0 | 4.0 | 6.0 |
| Altman Z'' | 9.5 | 8.5 | 8.7 | 7.3 | 6.1 | 6.8 | 7.2 | 7.5 | 7.4 | 7.6 |
| Accruals ratio | −0.7% | −6.1% | −3.2% | −4.1% | −11.5% | −2.1% | −1.6% | −1.1% | 0.6% | −3.2% |
Source: SEC EDGAR XBRL filings (CIK 0001058290). Data updated October 9, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only — not investment advice. Check the original filings before relying on any figure.